Hair Million promotes hair growth in both women and men. It is made of healthy and safe herbs that have been well documented and in use for thousands of years, especially in Asia. Although these herbs have not yet been scientifically proven by placebo-controlled clinical trials nor the ingedients of the herbs charaterized in laboratory, the herbal formula has been proven efficacious anecdotally in a number of people who experience hair thinning and hair loss. There are other herbs and nutritions that also work in anecdotal cases. For instance, Saw palmetto fruit extract have beens shown effective. Other herbs, such as sage, evening primrose, horse chestnut, horsetail, rosemary have been suggested. B vitamins, especially biotin might help as well.

Hair Million is a finest product that would ward off hair loss and promote hair growth, without side effect. Hair Million should be orally taken as suggested for a few months to see the positive effects: stopping hair thinning, and hair loss, and observing new hair growth. For some individuals, none of the hair growth products or methods would work, and the reasons are not always clear. People with alopecia areata would certainly benefit from Hair Million. Once you know it works for you, you could take it for months and years. It often results in complete restoration of hair.



  • Finasteride in the treatment of Taiwanese men with androgenetic alopecia: a 12-month open-label study.
  • Loss of cell adhesion in Dsg3bal-Pas mice with homozygous deletion mutation (2079del14) in the desmoglein 3 gene.
  • Idiopathic CD4+ T lymphocytopenia associated with disseminated flat warts and alopecia areata.
  • Implication of VEGF, steroid hormones and neuropeptides in hair follicle cell responses
  • Lupus panniculitis clinically simulating alopecia areata.
  • Effect of minoxidil on hair growth in androgenic alopecia in women
  • An endocrinopathy characterized by dysfunction of the pituitary-adrenal axis and alopecia universalis: supporting the entity of a triple H syndrome.
  • Alopecia universalis in a case of systemic lupus erythematosus.
  • A random study of Asian male androgenetic alopecia in Bangkok, Thailand.
  • Idiopathic CD4+ T lymphocytopenia associated with disseminated flat warts and alopecia areata.
  • Curly bare (cub), a new mouse mutation on chromosome 11 causing skin and hair abnormalities, and a modifier gene (mcub) on chromosome 5.
  • Approach to the adult female patient with diffuse nonscarring alopecia.
  • Kenogen. A new phase of the hair cycle?
  • Loss of cell adhesion in Dsg3bal-Pas mice with homozygous deletion mutation (2079del14) in the desmoglein 3 gene.
  • Postmenopausal frontal fibrosing alopecia.
  • Postmenopausal frontal fibrosing alopecia.
  • Primary follicular mucinosis: long-term follow-up of patients younger than 40 years with and without clonal T-cell receptor gene rearrangement.
  • Molecular mechanisms of androgenetic alopecia.
  • Interleukin-1 receptor antagonist allele 2 and familial alopecia areata.
  • Prevention of temporal alopecia following rhytidectomy: the prophylactic use of minoxidil. A study of 60 patients.
  • Notch/RBP-J Signaling Regulates Epidermis/Hair Fate Determination of Hair Follicular Stem Cells.
  • The hydraulic influence in androgen-related hair growth: implications in autoimmune disease.
  • Postmenopausal frontal fibrosing alopecia. Report of 3 cases
  • Curly bare (cub), a new mouse mutation on chromosome 11 causing skin and hair abnormalities, and a modifier gene (mcub) on chromosome 5.
  • Ovarian steroid cell tumor and a contralateral ovarian thecoma in a postmenopausal woman with severe hyperandrogenism.
  • Vitamin D3 analogs stimulate hair growth in nude mice.
  • Loss of cell adhesion in Dsg3bal-Pas mice with homozygous deletion mutation (2079del14) in the desmoglein 3 gene.
  • Hair Transplantation for Men with Advanced Degrees of Hair Loss
  • Female pattern hair loss.
  • Notch/RBP-J Signaling Regulates Epidermis/Hair Fate Determination of Hair Follicular Stem Cells.
  • Treatment of hyperandrogenic alopecia in women.
  • Treatment of hyperandrogenic alopecia in women.
  • Loss of cell adhesion in Dsg3bal-Pas mice with homozygous deletion mutation (2079del14) in the desmoglein 3 gene.
  • Mouse models for human hair loss disorders.
  • Notch/RBP-J Signaling Regulates Epidermis/Hair Fate Determination of Hair Follicular Stem Cells.
  • Dense-packing hair grafting technique for restoration of cicatricial alopecia
  • Curly bare (cub), a new mouse mutation on chromosome 11 causing skin and hair abnormalities, and a modifier gene (mcub) on chromosome 5.
  • The art of repair in surgical hair restoration--part II: the tactics of repair.
  • Alopecia areata: update on therapy
  • Primary follicular mucinosis: long-term follow-up of patients younger than 40 years with and without clonal T-cell receptor gene rearrangement.
  • Seventeen cases of alopecia areata: combination of SADBE topical immunotherapy with other therapies.
  • Relationship between irreversible alopecia and exposure to cyclophosphamide, thiotepa and carboplatin (CTC) in high-dose chemotherapy.
  • There is no clear association between low serum ferritin and chronic diffuse telogen hair loss.
  • Curly bare (cub), a new mouse mutation on chromosome 11 causing skin and hair abnormalities, and a modifier gene (mcub) on chromosome 5.
  • The art of repair in surgical hair restoration part I: basic repair strategies.
  • Primary follicular mucinosis: long-term follow-up of patients younger than 40 years with and without clonal T-cell receptor gene rearrangement.
  • The potential role of minoxidil in the hair transplantation setting.
  • Does the recipient site influence the hair growth characteristics in hair transplantation?
  • Androgenetic alopecia in the man
  • Steroidogenic isoenzymes in human hair and their potential role in androgenetic alopecia.
  • Idiopathic CD4+ T lymphocytopenia associated with disseminated flat warts and alopecia areata.
  • Postmenopausal frontal fibrosing alopecia.
  • Effect of minoxidil on hair growth in androgenic alopecia in women
  • Striae distensae - like lesions. A cause of scarring alopecia among children.
  • Curly bare (cub), a new mouse mutation on chromosome 11 causing skin and hair abnormalities, and a modifier gene (mcub) on chromosome 5.
  • Role of the Autoimmune Regulator (AIRE) gene in alopecia areata: Strong association of a potentially functional AIRE polymorphism with alopecia universalis.
  • 'Cyclic alopecia' in Msx2 mutants: defects in hair cycling and hair shaft differentiation.
  • Fas and c-kit are involved in the control of hair follicle melanocyte apoptosis and migration in chemotherapy-induced hair loss.
  • Seventeen cases of alopecia areata: combination of SADBE topical immunotherapy with other therapies.
  • Postmenopausal frontal fibrosing alopecia. Report of 3 cases



    Hair loss and hair growth online references:

    1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 |